Vaping for smoking cessation
Some clients might be considering using vaping devices. If so, they might be concerned about the safety of vaping, and whether vapes are an effective smoking cessation method. Health professionals play an important role in providing up-to-date information on the risks and efficacy of vaping for smoking cessation.
Vaping for smoking cessation is not a first-line treatment for smoking cessation. Consider TGA-approved and effective pharmacotherapies with behavioural support to manage cravings and withdrawals.
Clinical guidelines
Nicotine vaping products (NVPs) are not a first-line treatment for smoking cessation. There are currently no NVPs approved by the Therapeutic Goods Administration (TGA).
While there are established pathways for consumers to legally access unapproved NVPs with a valid prescription, these medicines have not been assessed by the TGA for safety, quality and efficacy.
There are other approved and effective smoking cessation first line treatments such as nicotine replacement therapy, varenicline and bupropion, which have been assessed by the TGA for safety, quality and efficacy.
There are also non-pharmaceutical approaches to smoking cessation such as behavioural counselling through Quitline. Combining behavioural support with approved medications has the strongest evidence base for success.
Prescribing vaping for smoking cessation
- The long-term health effects of NVPs are unknown
- The safety, efficacy and quality of NVPs have not been established
- The lack of uniformity in NVPs makes dosage difficult to control
- Patients should return to their health professional for regular monitoring
Further information
You can find out more about vaping for smoking cessation at the following sources:
Call NSW Quitline for advice on helping your clients quit.